Colgate-Palmolive Company (NYSE:CL) CMO Mukul Deoras sold 7,500 shares of the stock in a transaction on Friday, November 10th. The shares were sold at an average price of $73.28, for a total value of $549,600.00. Following the completion of the sale, the chief marketing officer now directly owns 45,217 shares of the company’s stock, valued at $3,313,501.76. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Colgate-Palmolive Company (NYSE CL) traded up $0.30 during mid-day trading on Monday, hitting $73.21. The stock had a trading volume of 2,523,600 shares, compared to its average volume of 3,635,420. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The company has a market cap of $64,286.08, a P/E ratio of 25.51, a price-to-earnings-growth ratio of 3.35 and a beta of 0.80. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the consensus estimate of $0.73. The company had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.73 EPS. analysts predict that Colgate-Palmolive Company will post 2.88 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.19%. Colgate-Palmolive’s payout ratio is 61.78%.

WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/11/13/mukul-deoras-sells-7500-shares-of-colgate-palmolive-company-cl-stock.html.

Hedge funds and other institutional investors have recently modified their holdings of the business. American Beacon Advisors Inc. bought a new position in Colgate-Palmolive in the 1st quarter worth about $102,000. Proficio Capital Partners LLC boosted its stake in Colgate-Palmolive by 16.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after purchasing an additional 207 shares during the period. Jacobi Capital Management LLC boosted its stake in Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares during the period. OLD Second National Bank of Aurora bought a new position in Colgate-Palmolive in the 2nd quarter worth about $109,000. Finally, Krilogy Financial LLC boosted its stake in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the period. Institutional investors and hedge funds own 73.87% of the company’s stock.

CL has been the subject of a number of analyst reports. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a research report on Monday, October 23rd. Morgan Stanley raised Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $75.00 to $84.00 in a research report on Monday, September 25th. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. SunTrust Banks, Inc. raised Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their price target for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. Finally, Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the stock. Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $76.67.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.